Our commercial teams are passionate about bringing our medicines to our customers around the world. It is an especially exciting time to join our company’s Immunology Team and our growing U.S. Pharma Business Unit as we prepare for potential launches in inflammatory bowel disease (IBD). The Immunology portfolio is a top corporate priority and a key growth driver for the U.S. Market and our company. We are currently recruiting for Director, IBD Field Strategy & Execution. As a key leader within the rapidly growing U.S. Immunology marketing team, this individual will play a pivotal role in enabling pre-launch, launch, and post-launch success by ensuring the field organization is prepared to execute with excellence in a highly dynamic environment. In this role, the candidate will be responsible for leading field strategy and execution across customer-facing teams to support key business objectives for our Ulcerative Colitis and Crohn’s Disease Launches. This role requires strong leadership, exceptional collaboration and communication, and demonstrated ability to lead through complexity to meet timelines and deliver results. This position will report to the Executive Director, IBD U.S. Commercial Lead and will lead field strategy and execution for our investigational phase 3 monoclonal antibody asset directed to tumor necrosis factor-like cytokine 1A (TL1A). This role will be based will be based in the Upper Gwynedd, PA office.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director